Suchergebnisse - "Latino, José Omar"

PubPharm (13)

1

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome

enthalten in: Immunologic research | 2019

von Udry, S. | Latino, J. | Belizna, C. | +3

2

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome

enthalten in: Immunologic research | 2019

von Udry, S. | Latino, J. | Belizna, C. | +3

3

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome

enthalten in: Immunologic research | 2019

von Udry, S. | Latino, J. | Belizna, C. | +3

4

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome

enthalten in: Immunologic research | 2019

von Udry, S. | Latino, J. | Belizna, C. | +3

5

HIBISCUS : Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome

enthalten in: Autoimmunity reviews | 2018

von Belizna, C. | Pregnolato, F. | Abad, S. | +78

6

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

7

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

8

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

9

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

10

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

enthalten in: Journal of assisted reproduction and genetics | 2018

von Aranda, F. | Udry, S. | Perés Wingeyer, S. | +6